Evidence map›Paper›PMID 35208212›Full record

ArticleMetabolites2022

Comprehensive Peak Characterization (CPC) in Untargeted LC-MS Analysis.

Kristian Pirttilä, David Balgoma, Johannes Rainer, Curt Pettersson, Mikael Hedeland, Carl Brunius

Abstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kristian PirttiläDepartment of Medicinal Chemistry, Uppsala University, SE-75123 Uppsala, Sweden.ORCID 0000-0002-5682-7408
David BalgomaDepartment of Medicinal Chemistry, Uppsala University, SE-75123 Uppsala, Sweden.
Johannes RainerInstitute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, 39100 Bolzano, Italy.ORCID 0000-0002-6977-7147
Curt PetterssonDepartment of Medicinal Chemistry, Uppsala University, SE-75123 Uppsala, Sweden.
Mikael HedelandDepartment of Medicinal Chemistry, Uppsala University, SE-75123 Uppsala, Sweden.ORCID 0000-0001-8962-2815
Carl BruniusDepartment of Biology and Biological Engineering, Chalmers University of Technology, SE-41296 Gothenburg, Sweden.

Funding

Disciplinary domain of medicine and pharmacy, Uppsala University N/ASwedish National Infrastructure for Biological Mass Spectrometry (BioMS) N/A
6 · The paper itself

Abstract

LC-MS-based untargeted metabolomics is heavily dependent on algorithms for automated peak detection and data preprocessing due to the complexity and size of the raw data generated. These algorithms are generally designed to be as inclusive as possible in order to minimize the number of missed peaks. This is known to result in an abundance of false positive peaks that further complicate downstream data processing and analysis. As a consequence, considerable effort is spent identifying features of interest that might represent peak detection artifacts. Here, we present the CPC algorithm, which allows automated characterization of detected peaks with subsequent filtering of low quality peaks using quality criteria familiar to analytical chemists. We provide a thorough description of the methods in addition to applying the algorithms to authentic metabolomics data. In the example presented, the algorithm removed about 35% of the peaks detected by XCMS, a majority of which exhibited a low signal-to-noise ratio. The algorithm is made available as an R-package and can be fully integrated into a standard XCMS workflow.

Indexed as

algorithmdata processingdata qualityfalse peaksmetabolomicspeak characterizationpeak detectionpeak filteringuntargetedXCMS

Identifiers

PMID35208212
PMCPMC8878835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.